Literature DB >> 31649158

Susceptibility-Weighted Imaging Findings in Aspartylglucosaminuria.

A Tokola1, M Laine2, R Tikkanen3, T Autti4.   

Abstract

BACKGROUND AND
PURPOSE: Aspartylglucosaminuria is a rare lysosomal storage disorder that causes slowly progressive, childhood-onset intellectual disability and motor deterioration. Previous studies have shown, for example, hypointensity in the thalami in patients with aspartylglucosaminuria on T2WI, especially in the pulvinar nuclei. Susceptibility-weighted imaging is a neuroimaging technique that uses tissue magnetic susceptibility to generate contrast and is able to visualize iron and other mineral deposits in the brain. SWI findings in aspartylglucosaminuria have not been reported previously.
MATERIALS AND METHODS: Twenty-one patients with aspartylglucosaminuria (10 girls; 7.4-15.0 years of age) underwent 3T MR imaging. The protocol included an SWI sequence, and the images were visually evaluated. Thirteen patients (6 girls, 7.4-15.0 years of age) had good-quality SWI. Eight patients had motion artifacts and were excluded from the visual analysis. Thirteen healthy children (8 girls, 7.3-14.1 years of age) were imaged as controls.
RESULTS: We found a considerably uniform distribution of decreased signal intensity in SWI in the thalamic nuclei in 13 patients with aspartylglucosaminuria. The most evident hypointensity was found in the pulvinar nuclei. Patchy hypointensities were also found especially in the medial and anterior thalamic nuclei. Moreover, some hypointensity was noted in globi pallidi and substantia nigra in older patients. The filtered-phase images indicated accumulation of paramagnetic compounds in these areas. No abnormal findings were seen in the SWI of the healthy controls.
CONCLUSIONS: SWI indicates accumulation of paramagnetic compounds in the thalamic nuclei in patients with aspartylglucosaminuria. The finding may raise the suspicion of this rare disease in clinical practice.
© 2019 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2019        PMID: 31649158      PMCID: PMC6975119          DOI: 10.3174/ajnr.A6288

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  28 in total

Review 1.  The cell biology of lysosomal storage disorders.

Authors:  Anthony H Futerman; Gerrit van Meer
Journal:  Nat Rev Mol Cell Biol       Date:  2004-07       Impact factor: 94.444

2.  Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism?

Authors:  Ferdinand Schweser; Andreas Deistung; Berengar Wendel Lehr; Jürgen Rainer Reichenbach
Journal:  Neuroimage       Date:  2010-10-30       Impact factor: 6.556

3.  Detailed profile of cognitive dysfunction in children with aspartylglucosaminuria.

Authors:  Elina Leena Harjunen; Minna Laine; Ritva Tikkanen; Päivi Helenius
Journal:  J Inherit Metab Dis       Date:  2019-09-08       Impact factor: 4.982

4.  Brain MRI findings in aspartylglucosaminuria.

Authors:  Anna M Tokola; Laura E Åberg; Taina H Autti
Journal:  J Neuroradiol       Date:  2015-05-27       Impact factor: 3.447

5.  Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping.

Authors:  Ferdinand Schweser; Andreas Deistung; Berengar W Lehr; Jürgen R Reichenbach
Journal:  Med Phys       Date:  2010-10       Impact factor: 4.071

6.  Mice with an aspartylglucosaminuria mutation similar to humans replicate the pathophysiology in patients.

Authors:  A Jalanko; K Tenhunen; C E McKinney; M E LaMarca; J Rapola; T Autti; R Joensuu; T Manninen; I Sipilä; S Ikonen; P Riekkinen; E I Ginns; L Peltonen
Journal:  Hum Mol Genet       Date:  1998-02       Impact factor: 6.150

Review 7.  Susceptibility-weighted imaging: technical aspects and clinical applications, part 1.

Authors:  E M Haacke; S Mittal; Z Wu; J Neelavalli; Y-C N Cheng
Journal:  AJNR Am J Neuroradiol       Date:  2008-11-27       Impact factor: 3.825

Review 8.  Lysosomal storage disorders and iron.

Authors:  Jose Miguel Bras
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

Review 9.  The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine.

Authors:  Peter D Stenson; Matthew Mort; Edward V Ball; Katy Shaw; Andrew Phillips; David N Cooper
Journal:  Hum Genet       Date:  2014-01       Impact factor: 4.132

10.  Identification of Small Molecule Compounds for Pharmacological Chaperone Therapy of Aspartylglucosaminuria.

Authors:  Antje Banning; Christina Gülec; Juha Rouvinen; Steven J Gray; Ritva Tikkanen
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

View more
  2 in total

Review 1.  Modeling Rare Human Disorders in Mice: The Finnish Disease Heritage.

Authors:  Tomáš Zárybnický; Anne Heikkinen; Salla M Kangas; Marika Karikoski; Guillermo Antonio Martínez-Nieto; Miia H Salo; Johanna Uusimaa; Reetta Vuolteenaho; Reetta Hinttala; Petra Sipilä; Satu Kuure
Journal:  Cells       Date:  2021-11-13       Impact factor: 6.600

2.  A cross-sectional natural history study of aspartylglucosaminuria.

Authors:  Kimberly Goodspeed; Daniel Horton; Andrea Lowden; Peter V Sguigna; Timothy Booth; Zhiyue J Wang; Veronica Bordes Edgar
Journal:  JIMD Rep       Date:  2022-07-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.